Guidelines

Two senators urge GSK to end Shingrix shingles vaccine shortage
Although GlaxoSmithKline said it has developed a “fair and equitable” process to ship Shingrix, its new shingles vaccine, two U.S. senators are urging the drugmaker do more to boost inventory levels in the wake of a shortage.
Special attention for specialty pharmaceuticals
LexisNexis Risk Solutions Health Care’s Bobbie Riley and Bryan Eidex take a look at how pharmacies are tackling the growth of specialty and tools that should be in place when working with the high-dollar class of drugs.

Merz's Xeomin for adults gets FDA approval

Merz North America has received the green light from the Food and Drug Administration for Xeomin (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, in adult patients.
Albertsons piloted Idaho expanded prescribing before July 1 enactment

Albertsons pharmacies were given agency approval to pilot Idaho’s new prescribing authority, which took effect July 1, making it the first large retail chain pharmacy in the nation to offer these expanded services.
Medisca, FlavoRx partner on product roll out in Canada

Medisca's collaboration with FlavoRx will bring better tasting prescription medicines to children and pets in Canada.
Acadia gets FDA nod for Nuplazid in capsule, tablet strengths

Acadia received FDA approval for a new capsule dose formulation and tablet strength of Nuplazid.
Zydus Cadila gets FDA approval for Adalat CC, Questran generics

Drug firm Zydus Cadila has received the Food and Drug Administration’s nod for generic Adalat CC (nifedipine extended-release tablets), and for generic Questran (cholestyramine for oral suspension).
Florida's drug price transparency law takes effect

Pharmacists in Florida can now share cost information with patients, thanks to a new law that took effect July 1.
FDA withdraws draft guidance on biosimilars

Key factors in the decision included comments noting that the number of reference product lots biosimilar developers would need to purchase under the draft guidance if it were finalized could impact cost and efficiency.
American Regent launches preservative-free generic Makena

The product will be available in 1 ml preservative-free single-dose vials in a dosage strength of 250 mg/ml.

Two senators urge GSK to end Shingrix shingles vaccine shortage

Special attention for specialty pharmaceuticals

Merz's Xeomin for adults gets FDA approval

Albertsons piloted Idaho expanded prescribing before July 1 enactment

Medisca, FlavoRx partner on product roll out in Canada

Acadia gets FDA nod for Nuplazid in capsule, tablet strengths

Zydus Cadila gets FDA approval for Adalat CC, Questran generics

Florida's drug price transparency law takes effect

FDA withdraws draft guidance on biosimilars

American Regent launches preservative-free generic Makena